| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.3M | -14.8% |
| R&D Expense | $2.4M | -6.0% |
| SG&A Expense | $2.8M | -15.1% |
| Operating Income | -$1.6M | -129.1% |
| Pre-tax Income | -$4.7M | -22.0% |
| Income Tax | -$29K | -139.5% |
| Net Income | -$4.7M | -18.9% |
| EPS (Basic) | -$0.01 | +0.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $759K | -33.7% |
| Accounts Receivable | $1.0M | -14.3% |
| Inventory | $418K | +42.0% |
| Current Assets | $2.7M | -9.5% |
| Total Assets | $3.6M | -15.0% |
| Current Liabilities | $43.8M | +8.9% |
| Total Liabilities | $44.1M | +8.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$239K | -133.9% |
| Capital Expenditures | $46K | +174.5% |
| Investing Cash Flow | -$140K | -124.0% |
| Financing Cash Flow | -$8K | +47.9% |
| Free Cash Flow | -$285K | -141.5% |
| Stockholders' Equity |
| -$40.4M |
| -11.5% |